SCHEMBL30837892

SCHEMBL30837892

COc1cc(Cn2c(=O)c3cc(OC(CF)CF)ccc3n(C3CCN(C=O)CC3)c2=O)ccc1OCc1ccc(F)cc1

nearest known ligand 0.85

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 10/20 0.85
PDE7B Q9NP56 5/20 0.85
PDE8A O60658 3/20 0.85
CSF1R P07333 2/20 0.40
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TSHR P16473 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ENPP2 Q13822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL101109 1.00 PDE7A (0.85) PDE7APDE7BPDE8ACSF1RMEN1
SCHEMBL100181 0.95 PDE7A (0.86) PDE7APDE7BPDE8ACSF1RMEN1
SCHEMBL100320 0.94 PDE7A (0.84) PDE7APDE7BPDE8ACSF1RMEN1
SCHEMBL30837773 0.94 PDE7A (0.84) PDE7APDE7BPDE8ACSF1RMEN1
SCHEMBL100704 0.92 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL30837881 0.92 PDE7A (1.00) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL100171 0.92 PDE7A (0.90) PDE7APDE7BPDE8AMEN1MAPT
SCHEMBL101113 0.91 PDE7A (0.82) PDE7APDE7BPDE8ACSF1RMEN1
SCHEMBL101023 0.91 PDE7A (0.70) PDE7APDE7BPDE8ACSF1RNPC1
SCHEMBL100224 0.91 PDE7A (0.89) PDE7APDE7BPDE8AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4572765-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE Mitodicure GmbH (DE) 2025-06-25 EP disclosed
WO-2024038089-A1 USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE MITODICURE GMBH (DE) 2024-02-22 WO disclosed